mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-11 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-07 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.26 |
2e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.26 |
1e-05 |